GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Maxigen Biotech Inc (TPE:1783) » Definitions » Total Inventories

Maxigen Biotech (TPE:1783) Total Inventories : NT$78.1 Mil (As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Maxigen Biotech Total Inventories?

Maxigen Biotech's total inventories for the quarter that ended in Mar. 2024 was NT$78.1 Mil. Maxigen Biotech's average total inventories from the quarter that ended in Dec. 2023 to the quarter that ended in Mar. 2024 was NT$81.7 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Maxigen Biotech's Net-Net Working Capital per share for the quarter that ended in Mar. 2024 was NT$4.93.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Maxigen Biotech's Days Inventory for the three months ended in Mar. 2024 was 189.55.

Inventory Turnover measures how fast the company turns over its inventory within a year. Maxigen Biotech's Inventory Turnover for the quarter that ended in Mar. 2024 was 0.48.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Maxigen Biotech's Inventory-to-Revenue for the quarter that ended in Mar. 2024 was 0.64.


Maxigen Biotech Total Inventories Historical Data

The historical data trend for Maxigen Biotech's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Maxigen Biotech Total Inventories Chart

Maxigen Biotech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Inventories
Get a 7-Day Free Trial Premium Member Only Premium Member Only 88.12 86.98 78.95 75.27 85.19

Maxigen Biotech Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Inventories Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 75.55 86.43 97.07 85.19 78.12

Maxigen Biotech Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.


Maxigen Biotech  (TPE:1783) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Maxigen Biotech's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2024 is

Net-Net Working Capital Per Share (Q: Mar. 2024 )
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(484.638+0.75 * 68.88+0.5 * 78.12-136.501
-0-0)/88.957
=4.93

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Maxigen Biotech's Days Inventory for the three months ended in Mar. 2024 is calculated as:

Days Inventory=Average Total Inventories (Q: Mar. 2024 )/Cost of Goods Sold (Q: Mar. 2024 )*Days in Period
=81.6525/39.308*365 / 4
=189.55

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Maxigen Biotech's Inventory Turnover for the quarter that ended in Mar. 2024 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Mar. 2024 ) / Average Total Inventories (Q: Mar. 2024 )
=39.308 / 81.6525
=0.48

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Maxigen Biotech's Inventory to Revenue for the quarter that ended in Mar. 2024 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=81.6525 / 127.058
=0.64

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.


Maxigen Biotech Total Inventories Related Terms

Thank you for viewing the detailed overview of Maxigen Biotech's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.


Maxigen Biotech (TPE:1783) Business Description

Traded in Other Exchanges
N/A
Address
No. 88, Keji 1st Rd, Guishan District, Taoyuan City, TWN, 333
Maxigen Biotech Inc specializes in the developing, manufacturing, and marketing of biomedical and cosmeceutical skincare products. It provides medical devices for orthopedic, ophthalmic, dental, and surgical applications. Skincare product categories include mask series, facial cleansing series, and body care series. The biomedical products segment is primarily engaged in the manufacturing and sales of collagen and bone materials, which forms the majority chunk of the revenue of the group. The consumer products segment is engaged in the manufacturing and sales of beauty care products.

Maxigen Biotech (TPE:1783) Headlines

No Headlines